Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Geusens

Showing results (171-180 of 210) with videos related to

Pageof 21
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2001
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaquesC R Dhore, J P Cleutjens, E Lutgens, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 23, 2017
Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosisO A Oshagbemi, J H M Driessen, A Pieffers, et al.
Annals of the Rheumatic Diseases|July 4, 2006
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hipF P Luyten, P Geusens, M Malaise, et al.
Maturitas|July 12, 2011
Vertebral fractures in women aged 50 years and older with clinical risk factors for fractures in primary careMartha van den Berg, Noortje A Verdijk, Joop P W van den Bergh, et al.
The New England Journal of Medicine|February 15, 2001
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study GroupM R McClung, P Geusens, P D Miller, et al.
Nature Clinical Practice. Rheumatology|April 10, 2008
Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspectivePiet P Geusens, Christian H Roux, David M Reid, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 8, 2017
The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS studyA Modi, S Sen, J D Adachi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 6, 2015
Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS studyA Modi, S Sen, J D Adachi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 4, 2015
Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohortS Bours, F de Vries, J P W van den Bergh, et al.
Annals of the Rheumatic Diseases|September 17, 2008
Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year studyB Combe, C Codreanu, U Fiocco, et al.
Pageof 21

Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2001
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaquesC R Dhore, J P Cleutjens, E Lutgens, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 23, 2017
Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosisO A Oshagbemi, J H M Driessen, A Pieffers, et al.
Annals of the Rheumatic Diseases|July 4, 2006
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hipF P Luyten, P Geusens, M Malaise, et al.
Maturitas|July 12, 2011
Vertebral fractures in women aged 50 years and older with clinical risk factors for fractures in primary careMartha van den Berg, Noortje A Verdijk, Joop P W van den Bergh, et al.
The New England Journal of Medicine|February 15, 2001
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study GroupM R McClung, P Geusens, P D Miller, et al.
Nature Clinical Practice. Rheumatology|April 10, 2008
Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspectivePiet P Geusens, Christian H Roux, David M Reid, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 8, 2017
The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS studyA Modi, S Sen, J D Adachi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 6, 2015
Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS studyA Modi, S Sen, J D Adachi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 4, 2015
Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohortS Bours, F de Vries, J P W van den Bergh, et al.
Annals of the Rheumatic Diseases|September 17, 2008
Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year studyB Combe, C Codreanu, U Fiocco, et al.
Pageof 21